GB Sciences Initiates Cannabis-based Therapy Clinical Trials Consulting Services Agreement with Worldwide Clinical Trials, Inc.

0

LAS VEGAS, July 17, 2017 /PRNewswire/ — GB Sciences, Inc. (GBLX) has signed a Consulting Services Agreement with Worldwide Clinical Trials, Inc. to evaluate the company’s intellectual property portfolio and to assist with pre-IND planning for its proprietary cannabis-based formulations. Dr. Murphy has participated in the IND application process for multiple small molecules and biologics with 19 therapeutic targets, across five divisions of the FDA. Dr. Murphy was also the Clinical Research and Excellence (CARE) Lifetime Achievement Award recipient for 2017.

LEAVE A REPLY